<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-135195" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Plasmacytoma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Iqbal</surname>
            <given-names>Qurrat Ul Ain</given-names>
          </name>
          <aff>Shaikh Zayed Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Majid</surname>
            <given-names>Haroon Javaid</given-names>
          </name>
          <aff>Shaikh Zayed Medical Complex</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Qurrat Ul Ain Iqbal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Haroon Javaid Majid declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-135195.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Plasmacytoma is a tumor of plasma cells of bony or soft tissue and can occur anywhere in the body without evidence of systemic disease. It may present as a solitary or multiple mass anywhere in the body. It can progress to multiple myeloma if not evaluated and appropriately managed. This activity reviews the disease process, evaluation, and management of Plasmacytoma and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the presentation of plasmacytoma and its types.</p></list-item><list-item><p>Identify the epidemiology of the disease.</p></list-item><list-item><p>Review the evaluation of plasmacytoma.</p></list-item><list-item><p>Outline the treatment options for patients with plasmacytoma.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=135195&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=135195">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-135195.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Plasmacytoma is a rare plasma cell dyscrasia that grows within the axial skeleton or soft tissue structures as solitary or multiple masses&#x000a0;without evidence of systemic disease. It is an early plasma cell malignancy and is considered an intermediate phase between monoclonal gammopathy of undetermined significance(MGUS) and multiple myeloma (MM).<xref ref-type="bibr" rid="article-135195.r1">[1]</xref><xref ref-type="bibr" rid="article-135195.r2">[2]</xref>&#x000a0;Plasmacytoma can be divided into the following types according to the International Myeloma Working Group:<xref ref-type="bibr" rid="article-135195.r3">[3]</xref></p>
        <p>
<bold>Solitary Plasmacytoma</bold>
</p>
        <p>It is further divided into:</p>
        <list list-type="bullet">
          <list-item>
            <p>Solitary plasmacytoma of bone (SPB), which arises from plasma cells of the bone marrow.</p>
          </list-item>
          <list-item>
            <p>Extramedullary plasmacytoma (EMP), which arises from plasma cells of the mucosal surfaces.</p>
          </list-item>
        </list>
        <p>
<bold>Multiple Solitary Plasmacytomas (MSP)</bold>
</p>
        <p>Solitary plasmacytoma is the most common form of plasmacytoma. Most cases of plasmacytomas cause paraproteinemia. Metastatic spread of plasmacytoma occurs to soft tissues frequently and occasionally to bones. Plasmacytoma is treated with surgery, radiotherapy, and chemotherapy as required. Therapy for local disease gives prolonged survival, and disseminated disease treatment gives longer remission.</p>
        <p>According to the World Health Organization (WHO) update, SPB is further composed of two subtypes:<xref ref-type="bibr" rid="article-135195.r2">[2]</xref><xref ref-type="bibr" rid="article-135195.r4">[4]</xref></p>
        <list list-type="order">
          <list-item>
            <p>SPB with minimal bone marrow involvement:SPB type that has less than 10% clonal marrow cells apart from the plasmacytoma itself. The rate of progression of this type of SPB to MM is 20-60% in 3 years.</p>
          </list-item>
          <list-item>
            <p>SPB with no bone marrow involvement: SPB type that lacks clonal marrow cells apart from the plasmacytoma. The rate of progression of this type to MM is 10% in 3 years.</p>
          </list-item>
        </list>
        <p>MSP consists of monoclonal cell infiltrates in one or more lytic bone lesions or extramedullary tissue. Only a few cases of MSP have been reported. Imaging modalities used for solitary plasmacytoma may reveal the presence of multiple lesions leading to MSP diagnosis. MSP is diagnosed in up to 5% of cases of solitary plasmacytoma.<xref ref-type="bibr" rid="article-135195.r3">[3]</xref>&#x000a0;Long term prognosis of MSP is not clear. Surgery, radiotherapy, chemotherapy, and stem cell transplantation are indicated for the treatment of MSP.<xref ref-type="bibr" rid="article-135195.r5">[5]</xref><xref ref-type="bibr" rid="article-135195.r3">[3]</xref><xref ref-type="bibr" rid="article-135195.r6">[6]</xref></p>
      </sec>
      <sec id="article-135195.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of plasmacytoma is unknown.<xref ref-type="bibr" rid="article-135195.r7">[7]</xref><xref ref-type="bibr" rid="article-135195.r8">[8]</xref>&#x000a0;However, it is suggested that EMP may be caused by inhalation of chemicals, chronic stimulation, an overdose of irradiation, viral infection, and genetic disorders in the reticuloendothelial system.<xref ref-type="bibr" rid="article-135195.r9">[9]</xref></p>
      </sec>
      <sec id="article-135195.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Plasmacytoma is a rare disease, with SPB being the most common type. Solitary plasmacytoma has an annual incidence of fewer than 450 cases. The incidence of SPB is 40% more than EMP, with SPB constituting 2% to 5% of all plasma cell malignancies and EMP constituting 4% of all plasma cell malignancies.<xref ref-type="bibr" rid="article-135195.r1">[1]</xref>&#x000a0;Plasmacytoma is prevalent in older individuals, African Americans, and males.<xref ref-type="bibr" rid="article-135195.r10">[10]</xref>&#x000a0;It presents in the middle to old aged people with the mean age of presentation of 55&#x000a0;to 60 years.<xref ref-type="bibr" rid="article-135195.r11">[11]</xref>&#x000a0;Plasmacytoma is more prevalent in males than females, with a male to female ratio of 2&#x000a0;to 1 in SPB and 3:1 in EMP.</p>
      </sec>
      <sec id="article-135195.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Plasmacytomas share many biological features of other plasma cell disorders and can arise in any part of the body. SPB arises from plasma cells of the bone marrow, and EMP arises from the plasma cells of mucosal surfaces. According to some authors, EMP and marginal zone B-cell lymphomas share many histological and clinical similarities, with EMP having an extensive degree of plasmacytic differentiation. Interleukin-6 (IL-6) is considered the principal growth factor in plasma cell disorders.<xref ref-type="bibr" rid="article-135195.r12">[12]</xref>&#x000a0;Cytogenetic studies show that losses of chromosome 13 arm 1p and 14q and gains in arm 19,1q and 9q play an essential part in tumorigenesis of plasmacytoma.<xref ref-type="bibr" rid="article-135195.r13">[13]</xref>&#x000a0;High histological grade and angiogenesis in plasmacytoma are associated with increased progression to multiple myeloma, and plasmacytoma is considered an intermediate phase from the conversion of MGUS.<xref ref-type="bibr" rid="article-135195.r12">[12]</xref><xref ref-type="bibr" rid="article-135195.r14">[14]</xref>&#x000a0;&#x000a0;</p>
        <p>The occurrence of plasmacytoma at the surgical wound site may be due to direct wound contamination, host immune response, or tumor manipulation and aerosolization, among other factors. A dominant theory explaining the pathophysiology of plasmacytoma explains the increased expression of stromal cell-derived factor 1 (SDF-1) in areas of inflammation and trauma, which is a highly potent immune cell attractant. After chemotherapy, myeloma cells expressing CXCR-4 chemokine receptors attach to SDF-1.<xref ref-type="bibr" rid="article-135195.r15">[15]</xref>&#x000a0;The release of inflammatory cytokines causes proliferation of these plasma cells leading to tumor formation.<xref ref-type="bibr" rid="article-135195.r15">[15]</xref></p>
      </sec>
      <sec id="article-135195.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Routine hematoxylin and eosin stain is used for plasmacytoma. The histologic picture resembles multiple myeloma and contains dense infiltrate of plasmablastic or anaplastic plasma cells that may be mature or immature.<xref ref-type="bibr" rid="article-135195.r16">[16]</xref>&#x000a0;Amyloid deposits may be seen in extraosseous tumor mass as pink deposits containing multinucleated giant cells.</p>
      </sec>
      <sec id="article-135195.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>SPB presents with pain in the bones containing red bone marrow, e.g., ribs, vertebrae(thoracic more than lumber and cervical), femur, and pelvis.<xref ref-type="bibr" rid="article-135195.r3">[3]</xref><xref ref-type="bibr" rid="article-135195.r17">[17]</xref>&#x000a0;An uncommon presentation is in the skull with headaches, diplopia, strabismus, exophytic mass, otalgia, and dizziness.<xref ref-type="bibr" rid="article-135195.r18">[18]</xref><xref ref-type="bibr" rid="article-135195.r19">[19]</xref><xref ref-type="bibr" rid="article-135195.r20">[20]</xref>&#x000a0;Compression fractures of bones may occur with infiltrating bony lesions along with signs of local soft tissue damage. Significant vertebral involvement may lead to the involvement of the spinal cord or nerve root.</p>
        <p>EMP can occur anywhere in the body with 80% to 90% in the head and neck region and aerodigestive tract, mainly in the oral cavity, tonsillar fossa, nasal cavity, and paranasal sinuses, which may present with headache, nasal discharge, dysphagia, sore throat, epistaxis, and nasal obstruction.<xref ref-type="bibr" rid="article-135195.r17">[17]</xref><xref ref-type="bibr" rid="article-135195.r21">[21]</xref><xref ref-type="bibr" rid="article-135195.r22">[22]</xref>&#x000a0;</p>
        <p>Uncommon presentations include involvement of the larynx causing hoarseness, dysphonia, dyspnea, airway obstruction, and wheezing.<xref ref-type="bibr" rid="article-135195.r23">[23]</xref></p>
        <p>Gastrointestinal involvement is rare and presents with epigastric pain, hemoptysis, loss of appetite, bleeding, and abdominal discomfort. Involvement of mesentery is also seen, with only 10 cases reported.<xref ref-type="bibr" rid="article-135195.r24">[24]</xref><xref ref-type="bibr" rid="article-135195.r25">[25]</xref><xref ref-type="bibr" rid="article-135195.r26">[26]</xref></p>
        <p>Plasmacytoma may mimic a pulmonary tumor and present as a nodular parenchymal or perihilar opacity, associated with mediastinal lymphadenopathy, rarely alveolar interstitial or endobronchial damage.<xref ref-type="bibr" rid="article-135195.r27">[27]</xref>&#x000a0;It may also be rarely present in the thyroid, causing thyromegaly.<xref ref-type="bibr" rid="article-135195.r28">[28]</xref></p>
      </sec>
      <sec id="article-135195.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Laboratory Studies</bold>
</p>
        <p>Monoclonal proteins in serum or urine are detected. According to the diagnostic criteria, no M-protein should be detected on immunofixation of the serum and urine. Still, approximately 50% of patients show a small M-protein in the serum or urine.<xref ref-type="bibr" rid="article-135195.r3">[3]</xref>&#x000a0;&#x000a0;</p>
        <p>Uninvolved immunoglobulins and other blood tests are in average values.</p>
        <p>
<bold>Histol</bold>
<bold>ogy</bold>
</p>
        <p>Lesional biopsy or fine-needle aspiration techniques are used to diagnose plasmacytoma. In the case of the spine, fluoroscopic guided biopsy or CT guided lesional biopsy is used.&#x000a0;</p>
        <p>Tissue biopsy in SPB shows infiltration of monoclonal cells, and EMP shows submucosal growth and may require excision or tissue biopsy according to the location. A biopsy is done to check the phenotype of plasma cells. Additionally, bone marrow aspiration or trephine biopsy is done to rule out multiple myeloma. Furthermore, an immunohistological analysis is performed to check the presence of CD138 and CD38 markers.</p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Plain film radiography, MRI and PET CT are used to assess the lesion. Whole-body CT/MRI is used to detect other primary lesions elsewhere in the body.<xref ref-type="bibr" rid="article-135195.r17">[17]</xref><xref ref-type="bibr" rid="article-135195.r21">[21]</xref></p>
        <p>MRI due to better soft-tissue contrast and multiplanar images is a better modality for evaluating radiation volumes in plasmacytomas and the staging of the disease. It is also helpful in the verification of tumor reduction after therapy.<xref ref-type="bibr" rid="article-135195.r29">[29]</xref></p>
        <p>Features suggesting plasmacytoma include bulky soft tissue mass and features of high cellularity exhibited by relatively isointense T2 weighted MRI images.<xref ref-type="bibr" rid="article-135195.r22">[22]</xref>&#x000a0;</p>
        <p>Other imaging techniques include flow cytometry or kappa lambda labeling to check the degree of clonal plasma cell infiltration. Moreover, endoscopy is used to detect any associated lesions, resectability, mass effect, and destruction of surrounding tissue in EP. In addition to CT, which is used to detect underlying bony abnormalities, 18 fluorodeoxyglucose (18F-FDG) PET/CT is used in patients when MRI cannot be done.<xref ref-type="bibr" rid="article-135195.r30">[30]</xref></p>
        <p>Patients with plasmacytoma should be evaluated to exclude systemic disease by performing skeletal surveys, bone marrow biopsy, and blood tests. MM should be ruled out by performing the recommended tests, including spine MRI or FDG-PET, multicolor flow cytometry (MFC), immunoglobulins levels, and free light chain levels. Evaluation and diagnosis of systemic disease in this way may reduce the percentage of patients with plasmacytoma evolving into MM.<xref ref-type="bibr" rid="article-135195.r11">[11]</xref></p>
        <p>According to the international myeloma working group, the diagnostic criteria for plasmacytoma is as follows:<xref ref-type="bibr" rid="article-135195.r3">[3]</xref></p>
        <p>
<bold>SPB</bold>
</p>
        <p>One bone lesion containing clonal plasma cells, absence of M-protein in serum and urine (may be present in some cases), bone marrow histology not consistent with MM, normal skeletal survey, no end-organ damage.</p>
        <p>
<bold>EMP&#x000a0;</bold>
</p>
        <p>Extramedullary tumor of clonal plasma cells, absence of M-protein in serum and urine (may be present in some cases), normal bone marrow, normal skeletal survey, no end-organ damage.</p>
        <p>
<bold>MSP</bold>
</p>
        <p>More than one bone lesion or extramedullary tumor of plasma cells that may be recurrent, absence of M-protein in serum and urine (may be present in some cases), normal bone marrow, normal skeletal survey, no end-organ damage.</p>
      </sec>
      <sec id="article-135195.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Plasmacytomas are treated with radiation therapy (RT), surgery, and chemotherapy as required, given the disease condition.</p>
        <p>
<bold>Radiotherapy</bold>
</p>
        <p>Plasmacytoma is radiosensitive, and radiotherapy is the treatment of choice in SPB and EMP, which helps achieve an 80% control rate.<xref ref-type="bibr" rid="article-135195.r17">[17]</xref><xref ref-type="bibr" rid="article-135195.r11">[11]</xref><xref ref-type="bibr" rid="article-135195.r31">[31]</xref><xref ref-type="bibr" rid="article-135195.r21">[21]</xref>&#x000a0;</p>
        <p>Fractionated radiotherapy dose of 40-50 Gy over a duration of 4 weeks is given at the rate of 1.8&#x000a0;to 2.0 Gy per fraction.<xref ref-type="bibr" rid="article-135195.r17">[17]</xref>&#x000a0;&#x000a0;</p>
        <p>Conformal RT with parallel fields is commonly used to cover planning target volume (PTV). However, intensely modulated radiotherapy (IMRT) may be used to spare important structures like eyes and glands.</p>
        <p>The treatment field includes the tumor along with a 1.5&#x000a0;to 2.0 cm tumor-free margin. Furthermore, some authors recommend including the whole bone-in RT margins due to fear of recurrence, while others recommend the partially involved bone to be included in radiation therapy.<xref ref-type="bibr" rid="article-135195.r29">[29]</xref>&#x000a0;In cases of vertebral involvement, RT fields include 1&#x000a0;or 2 vertebrae above and below the affected vertebral level. Lymph node involvement in the radiation field is recommended if lymph nodes are involved in the disease process. The addition of regional lymph nodes in the radiation margin when not involved in the disease process decreases the recurrence rate. Still, it is associated with increased morbidity and hence not preferred.</p>
        <p>
<bold>Surgery</bold>
</p>
        <p>Some patients get partial or complete removal of tumors for diagnostic purposes. For therapeutic purposes, surgery combined with RT provides better progression-free survival (PFS). Radical surgery of head and neck plasmacytoma should be avoided as these tumors are highly radiosensitive, and radical surgery is mutilating. In other areas, surgery should be done where feasible. Moreover, surgery is also indicated for vertebral instability, fractures, or neurologic involvement. RT can also be delayed after surgery. However, surgery without RT shows increased rates of recurrence.<xref ref-type="bibr" rid="article-135195.r17">[17]</xref><xref ref-type="bibr" rid="article-135195.r29">[29]</xref>&#x000a0;</p>
        <p>
<bold>Chemotherapy</bold>
</p>
        <p>In most studies, chemotherapy shows no beneficial effect on disease control or prevention of complications. Chemotherapy does not decrease the incidence of progression of plasmacytoma to multiple myeloma (MM), but it does increase the duration of progression to MM. Adjuvant chemotherapy may be considered for tumors greater than 5cm and in tumors unresponsive to RT.<xref ref-type="bibr" rid="article-135195.r17">[17]</xref><xref ref-type="bibr" rid="article-135195.r29">[29]</xref>&#x000a0;</p>
        <p>
<bold>Autologous Stem Cell transplantation (ASCT)</bold>
</p>
        <p>ASCT is indicated in patients with high risk, recurrent and large numbers of solitary plasmacytoma. Trials have been conducted in patients with recurrent SPB in the radiation zone, distal recurrence, and high-risk plasmacytomas, showing promising results.<xref ref-type="bibr" rid="article-135195.r32">[32]</xref><xref ref-type="bibr" rid="article-135195.r33">[33]</xref></p>
      </sec>
      <sec id="article-135195.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Plasmacytoma shows a few similarities with other diseases and hence needs to be differentiated from them. Differential diagnosis of plasmacytoma includes:</p>
        <p>
<bold>Multiple Myeloma (MM)</bold>
</p>
        <p>Multiple myeloma is a tumor of plasma cells. Plasmacytoma may progress to multiple myeloma over 2-3 years. Plasmacytoma is a localized bone disease&#x000a0;and is further differentiated from multiple myeloma by the presence of CRABS (hypercalcemia, renal failure, anemia, bone disease), multiple lytic bone lesions, end-organ damage, and serum or urinary monoclonal proteins.<xref ref-type="bibr" rid="article-135195.r5">[5]</xref><xref ref-type="bibr" rid="article-135195.r34">[34]</xref><xref ref-type="bibr" rid="article-135195.r29">[29]</xref><xref ref-type="bibr" rid="article-135195.r34">[34]</xref></p>
        <p>
<bold>Non-Hodgkin Lymphoma (NHL)</bold>
</p>
        <p>NHL, in some cases, shows plasmacytic differentiation, which makes it difficult to differentiate them from plasmacytoma. In these cases, immunophenotyping can be used to differentiate these entities&#x02014;plasma cells in lymphoma express CD19 and CD45. The phenotype of SPB lesion is similar to that of myeloma, but that of EMP lesion is similar to lymphomas suggesting that they may represent NHL with plasmacytic differentiation.<xref ref-type="bibr" rid="article-135195.r35">[35]</xref>&#x000a0;&#x000a0;</p>
        <p>
<bold>Reactive Plasmacytosis</bold>
<bold/>
</p>
        <p>It consists of follicular hyperplasia. There is no light chain restriction in reactive plasmacytosis as compared to plasmacytoma.</p>
        <p>
<bold>Plasmablastic Lymphoma</bold>
<bold/>
</p>
        <p>The tumor has plasmablastic morphology, often occurs in HIV-positive or immunosuppressed individuals. It occurs in the oral cavity or the mucosal surfaces of the head. It is associated with the Epstein-Barr virus.</p>
      </sec>
      <sec id="article-135195.s11" sec-type="Staging">
        <title>Staging</title>
        <p>Soft tissue plasmacytoma staging is as follows:<xref ref-type="bibr" rid="article-135195.r36">[36]</xref>&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Limited to extramedullary site</p>
          </list-item>
          <list-item>
            <p>Involvement of the regional lymph nodes</p>
          </list-item>
          <list-item>
            <p>Multiple metastases&#x000a0;</p>
          </list-item>
        </list>
        <p>Extramedullary plasmacytoma staging is also done using a staging system for multiple myeloma because of the lack of a unique staging system of EMP to check survival and subsequently design treatment.<xref ref-type="bibr" rid="article-135195.r37">[37]</xref>&#x000a0;Two prognostic factors for its staging include lymph node metastasis and tumor size more than 5 cm.</p>
        <list list-type="bullet">
          <list-item>
            <p>Stage 1: Absence of both factors</p>
          </list-item>
          <list-item>
            <p>Stage 2: The presence of one factor</p>
          </list-item>
          <list-item>
            <p>Stage 3: The presence of both factors&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-135195.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The median time of progression to MM is 2&#x000a0;to 3 years. SBP has a poor prognosis and an increased progression to MM as compared to EMP.<xref ref-type="bibr" rid="article-135195.r38">[38]</xref>&#x000a0;SPB progresses to MM in 50% of cases, and EMP progresses to MM in 15% of cases.<xref ref-type="bibr" rid="article-135195.r3">[3]</xref></p>
        <p>The causes of poor prognosis include local recurrence, incomplete resection with functional damage, local lymph node metastasis, progression to MM, or new bone lesions formation with MM. Anaplastic plasmacytomas with high histologic grade and increased vascularity are a poor prognostic factor. For SPB, the poor prognostic factors include:</p>
        <list list-type="order">
          <list-item>
            <p>&#x000a0;&#x000a0;Age more than 40 years</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Tumour size of 5cm or more</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Spine lesions</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Neurologic symptoms associated with SPB&#x000a0;</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;RT dose<xref ref-type="bibr" rid="article-135195.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Existence of light chains&#x000a0;</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;High serum M protein levels<xref ref-type="bibr" rid="article-135195.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Persistence of M proteins after treatment</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Bone marrow infiltration by clonal plasma cells</p>
          </list-item>
          <list-item>
            <p>&#x000a0;&#x000a0;Osteopenia<xref ref-type="bibr" rid="article-135195.r12">[12]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>The prognostic factors for EP are unclear due to fewer cases and changing biological behavior.<xref ref-type="bibr" rid="article-135195.r40">[40]</xref>&#x000a0;Age, size and grade of tumor, origin (extramedullary versus bone), regional lymph node metastasis, serum M-protein, light chains, and RT dose are associated factors.<xref ref-type="bibr" rid="article-135195.r40">[40]</xref><xref ref-type="bibr" rid="article-135195.r29">[29]</xref><xref ref-type="bibr" rid="article-135195.r41">[41]</xref></p>
      </sec>
      <sec id="article-135195.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Plasmacytoma can occur anywhere in the body and leads to different complications.</p>
        <p>SPB causes lytic bone lesions that lead to bone pain and fractures of bones,&#x000a0;and associated nerve and soft tissue damages.<xref ref-type="bibr" rid="article-135195.r42">[42]</xref></p>
        <p>POEMS (polyneuropathy, organomegaly, endocrinopathy, multiple myeloma, and skin changes) syndrome is a paraneoplastic disorder associated with plasmacytoma in the bone.<xref ref-type="bibr" rid="article-135195.r43">[43]</xref></p>
        <p>Plasma cell disorders produce immunoglobulins that lead to relative immunodeficiency reducing antigen immune response.<xref ref-type="bibr" rid="article-135195.r42">[42]</xref></p>
        <p>Renal impairment is primarily related to light chains with decreased molecular weight eliminated as the Bence&#x02013;Jones protein in the urine as described in a case of plasmacytoma in the chest wall of a 44 years old male.<xref ref-type="bibr" rid="article-135195.r44">[44]</xref>&#x000a0;Kidney failure may result from reduced immunoglobulin elimination in the urine as immunoglobulins produced by plasmacytoma may be insoluble at cold temperatures. Cryoglobulinemia has been reported in cases where chronic Hepatitis C is associated with plasmacytoma. Amyloidosis may also be a consequence of light chain production by plasmacytoma.<xref ref-type="bibr" rid="article-135195.r42">[42]</xref>&#x000a0;A recent case report published in 2019 reported the association of acquired von Willebrand syndrome with intracranial plasmacytoma.<xref ref-type="bibr" rid="article-135195.r45">[45]</xref></p>
        <p>Plasmacytoma is also associated with gastrointestinal bleeding in some cases of MM.<xref ref-type="bibr" rid="article-135195.r46">[46]</xref></p>
        <p>A rare case was reported in which an extramedullary plasmacytoma was ulcerating through the gastric mucosa and presenting as a massive upper GI bleed. Such cases can be complicated by obstruction and perforation in the gastrointestinal system.<xref ref-type="bibr" rid="article-135195.r47">[47]</xref></p>
        <p>Moreover, drug toxicity should be considered if the patient is treated with melphalan, as certain complications like acute leukemia and sepsis are well-known complications of chemotherapy-induced neutropenia.<xref ref-type="bibr" rid="article-135195.r48">[48]</xref>&#x000a0;Additionally, thalidomide-induced thrombosis has also been reported.<xref ref-type="bibr" rid="article-135195.r49">[49]</xref></p>
      </sec>
      <sec id="article-135195.s14" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Patients treated for plasmacytoma need lifelong follow-up. Evaluation is done at a six-week interval for the first six months, and clinical visits are prolonged after that.<xref ref-type="bibr" rid="article-135195.r29">[29]</xref>&#x000a0;Evaluation includes complete blood count, complete metabolic panel, C reactive protein, erythrocyte sedimentation rate, M protein, and skeletal bone survey.</p>
        <p>NCCN recommends yearly imaging for five years by the same techniques used at diagnosis. Patients with SPB and EMP are also recommended for follow-up evaluation with orthopedics and ear, nose, throat department, respectively.</p>
      </sec>
      <sec id="article-135195.s15" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education is essential in every disease as it can help them understand their condition and get the appropriate treatment. In the case of plasmacytoma, discussion topics with patients include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Understanding the disease</p>
          </list-item>
          <list-item>
            <p>Disease workup&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Complications of disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Possible treatment options and outcomes</p>
          </list-item>
          <list-item>
            <p>Possibility of disease recurrence and progression</p>
          </list-item>
          <list-item>
            <p>Counseling about long term followup</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-135195.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of plasmacytoma requires close cooperation by different departments. Patients getting referred from the primary care physician for further management should be evaluated and treated by an interprofessional approach, including a team of radiotherapists, hematologists, surgeons, and oncologists.&#x000a0;Collaboration with nurses, pharmacists, and psychologists (if required) is essential for overall patient care. After treatment, patients need to continue to follow up. Patients need to be checked for recurrence or progression of the disease and may be referred to orthopedics or the ear, nose, throat department.&#x000a0;</p>
        <p>In case of occurrence of new bone pain, additional workup and imaging should be done.<xref ref-type="bibr" rid="article-135195.r29">[29]</xref></p>
        <p>Care should be taken to check for recurrence and progression of the disease to multiple myeloma. Early diagnosis, treatment, and careful monitoring may help provide better healthcare to the patients and improve their quality of life affected by the disease.</p>
      </sec>
      <sec id="article-135195.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=135195&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=135195">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/plasmacytoma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=135195">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/135195/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=135195">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-135195.s18">
        <fig id="article-135195.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Plasmacytoma Contributed by Shaikh Zayed Hospital</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="PHOTO-2021-06-12-10-19-28" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-135195.s19">
        <title>References</title>
        <ref id="article-135195.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Ullrich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hamerla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Surov</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Extramedullary Plasmacytoma].</article-title>
            <source>Rofo</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>190</volume>
            <issue>11</issue>
            <fpage>1006</fpage>
            <page-range>1006-1009</page-range>
            <pub-id pub-id-type="pmid">30296807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rajkumar</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Updated Diagnostic Criteria and Staging System for Multiple Myeloma.</article-title>
            <source>Am Soc Clin Oncol Educ Book</source>
            <year>2016</year>
            <volume>35</volume>
            <fpage>e418</fpage>
            <page-range>e418-23</page-range>
            <pub-id pub-id-type="pmid">27249749</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <collab>International Myeloma Working Group</collab>
            <article-title>Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.</article-title>
            <source>Br J Haematol</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>121</volume>
            <issue>5</issue>
            <fpage>749</fpage>
            <page-range>749-57</page-range>
            <pub-id pub-id-type="pmid">12780789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohana</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rouvio</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Nalbandyan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sheinis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Benharroch</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Classification of Solitary Plasmacytoma, Is it more Intricate than Presently Suggested? A Commentary.</article-title>
            <source>J Cancer</source>
            <year>2018</year>
            <volume>9</volume>
            <issue>21</issue>
            <fpage>3894</fpage>
            <page-range>3894-3897</page-range>
            <pub-id pub-id-type="pmid">30410592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dattolo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Allinovi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Michelassi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pizzarelli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Multiple solitary plasmacytoma with multifocal bone involvement. First clinical case report in a uraemic patient.</article-title>
            <source>BMJ Case Rep</source>
            <year>2013</year>
            <month>May</month>
            <day>23</day>
            <volume>2013</volume>
            <pub-id pub-id-type="pmid">23709144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ooi</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Chim</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Khong</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomas.</article-title>
            <source>AJR Am J Roentgenol</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>186</volume>
            <issue>3</issue>
            <fpage>821</fpage>
            <page-range>821-7</page-range>
            <pub-id pub-id-type="pmid">16498114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lombardo</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Maito</surname>
                <given-names>FLDM</given-names>
              </name>
              <name>
                <surname>Heitz</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Solitary plasmacytoma of the jaws: therapeutical considerations and prognosis based on a case reports systematic survey.</article-title>
            <source>Braz J Otorhinolaryngol</source>
            <year>2018</year>
            <season>Nov-Dec</season>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>790</fpage>
            <page-range>790-798</page-range>
            <pub-id pub-id-type="pmid">29941386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lalla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vinciguerra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lissoni</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arrigoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lira Luce</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abati</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Solitary Extramedullary Plasmacytoma Presenting as Asymptomatic Palatal Erythroplakia: Report of a Case.</article-title>
            <source>Int J Environ Res Public Health</source>
            <year>2021</year>
            <month>Apr</month>
            <day>04</day>
            <volume>18</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">33916539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gholizadeh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mehdipour</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rohani</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Esmaeili</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Extramedullary Plasmacytoma of the Oral Cavity in a Young Man: a Case Report.</article-title>
            <source>J Dent (Shiraz)</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>155</fpage>
            <page-range>155-8</page-range>
            <pub-id pub-id-type="pmid">27284562</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dores</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Landgren</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>McGlynn</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Linet</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Devesa</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004.</article-title>
            <source>Br J Haematol</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>144</volume>
            <issue>1</issue>
            <fpage>86</fpage>
            <page-range>86-94</page-range>
            <pub-id pub-id-type="pmid">19016727</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grammatico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scalzulli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Petrucci</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Solitary Plasmacytoma.</article-title>
            <source>Mediterr J Hematol Infect Dis</source>
            <year>2017</year>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>e2017052</fpage>
            <pub-id pub-id-type="pmid">28894561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Moulopoulos</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Maniatis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alexanian</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Solitary plasmacytoma of bone and asymptomatic multiple myeloma.</article-title>
            <source>Blood</source>
            <year>2000</year>
            <month>Sep</month>
            <day>15</day>
            <volume>96</volume>
            <issue>6</issue>
            <fpage>2037</fpage>
            <page-range>2037-44</page-range>
            <pub-id pub-id-type="pmid">10979944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aalto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nordling</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kivioja</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Karaharju</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Elomaa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Knuutila</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma.</article-title>
            <source>Genes Chromosomes Cancer</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>104</fpage>
            <page-range>104-7</page-range>
            <pub-id pub-id-type="pmid">10337993</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Low</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Mohd Tap</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Kew</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Ngiu</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Sridharan</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Non Secretory Multiple Myeloma With Extensive Extramedullary Plasmacytoma: A Diagnostic Dilemma.</article-title>
            <source>Iran J Radiol</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>e11760</fpage>
            <pub-id pub-id-type="pmid">26528383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaba</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Kenny</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Gundavaram</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Katz</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Escuadro</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Gaitonde</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Subcutaneous plasmacytoma metastasis precipitated by tunneled central venous catheter insertion.</article-title>
            <source>Case Rep Oncol</source>
            <year>2011</year>
            <month>May</month>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>315</fpage>
            <page-range>315-22</page-range>
            <pub-id pub-id-type="pmid">21738502</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torne</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Winkelmann</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Smolle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kerl</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinicopathologic study of cutaneous plasmacytoma.</article-title>
            <source>Int J Dermatol</source>
            <year>1990</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>8</issue>
            <fpage>562</fpage>
            <page-range>562-6</page-range>
            <pub-id pub-id-type="pmid">2242944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Paiva</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zamagni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Leleu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Blad&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kristinsson</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Touzeau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abildgaard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Terpos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Heusschen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ocio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Delforge</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sezer</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Beksac</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Merlini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Moreau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zweegman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Engelhardt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosi&#x000f1;ol</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.</article-title>
            <source>J Hematol Oncol</source>
            <year>2018</year>
            <month>Jan</month>
            <day>16</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <pub-id pub-id-type="pmid">29338789</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sweeney</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Rajkumar</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Jevremovic</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carlson</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Plasmacytoma of the Temporal Bone, a Great Imitator: Report of Seven Cases and Comprehensive Review of the Literature.</article-title>
            <source>Otol Neurotol</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>400</fpage>
            <page-range>400-407</page-range>
            <pub-id pub-id-type="pmid">28192381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Peng</surname>
                <given-names>XB</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>ZW</given-names>
              </name>
            </person-group>
            <article-title>Solitary plasmacytoma of the occipital bone: a case report.</article-title>
            <source>J Int Med Res</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>8</issue>
            <fpage>300060520914817</fpage>
            <pub-id pub-id-type="pmid">32780654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siyag</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soni</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Jakhotia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Plasmacytoma of the Skull-base: A Rare Tumor.</article-title>
            <source>Cureus</source>
            <year>2018</year>
            <month>Jan</month>
            <day>15</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>e2073</fpage>
            <pub-id pub-id-type="pmid">29552435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanrivermis Sayit</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Elmali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000fc;n</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Extramedullary Plasmacytoma of the Larynx with Radiologic and Histopathological Findings.</article-title>
            <source>Radiologia (Engl Ed)</source>
            <year>2020</year>
            <month>Oct</month>
            <day>22</day>
            <pub-id pub-id-type="pmid">33268135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Neuroimaging of plasmacytoma. A pictorial review.</article-title>
            <source>Neuroradiol J</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>431</fpage>
            <page-range>431-7</page-range>
            <pub-id pub-id-type="pmid">25196616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jizzini</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Extramedullary Plasmacytoma Involving the Trachea: A Case Report and Literature Review.</article-title>
            <source>J Emerg Med</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>e65</fpage>
            <page-range>e65-e67</page-range>
            <pub-id pub-id-type="pmid">31266689</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thambi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Plasmacytoma of the mesentery.</article-title>
            <source>J Postgrad Med</source>
            <year>2018</year>
            <season>Oct-Dec</season>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>255</fpage>
            <page-range>255-257</page-range>
            <pub-id pub-id-type="pmid">30207325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Galhotra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Saggar</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Primary isolated extramedullary plasmacytoma of mesentry: a rare case report.</article-title>
            <source>Gulf J Oncolog</source>
            <year>2012</year>
            <month>Jul</month>
            <issue>12</issue>
            <fpage>81</fpage>
            <page-range>81-4</page-range>
            <pub-id pub-id-type="pmid">22773223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitropoulou</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zizi-Sermpetzoglou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moschouris</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kountourogiannis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Myoteri</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dellaportas</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Solitary Plasmacytoma of the Mesentery: A Systematic Clinician's Diagnosis.</article-title>
            <source>Case Rep Oncol Med</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>5901503</fpage>
            <pub-id pub-id-type="pmid">28584670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elmorabit</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Derhem</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khouchani</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Solitary plasmacytoma of the lung treated with radiotherapy: case study and literature review].</article-title>
            <source>Pan Afr Med J</source>
            <year>2019</year>
            <volume>34</volume>
            <fpage>92</fpage>
            <pub-id pub-id-type="pmid">31934235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kandil</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Abdel Khalek</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Alabbas</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Thethi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Crawford</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Jaffe</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Plasmacytoma in the thyroid.</article-title>
            <source>J La State Med Soc</source>
            <year>2010</year>
            <season>Nov-Dec</season>
            <volume>162</volume>
            <issue>6</issue>
            <fpage>338</fpage>
            <page-range>338-40, 342</page-range>
            <pub-id pub-id-type="pmid">21294490</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kilciksiz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karakoyun-Celik</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Agaoglu</surname>
                <given-names>FY</given-names>
              </name>
              <name>
                <surname>Haydaroglu</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A review for solitary plasmacytoma of bone and extramedullary plasmacytoma.</article-title>
            <source>ScientificWorldJournal</source>
            <year>2012</year>
            <volume>2012</volume>
            <fpage>895765</fpage>
            <pub-id pub-id-type="pmid">22654647</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cavo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Terpos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nanni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moreau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lentzsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zweegman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hillengass</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Engelhardt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Usmani</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Vesole</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>San-Miguel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Mikhael</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>da Costa</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Zingaretti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abildgaard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goldschmidt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Orlowski</surname>
                <given-names>RZ</given-names>
              </name>
              <name>
                <surname>Chng</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Einsele</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lonial</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Barlogie</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Rajkumar</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Durie</surname>
                <given-names>BGM</given-names>
              </name>
              <name>
                <surname>Zamagni</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Role of <sup>18</sup>F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.</article-title>
            <source>Lancet Oncol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>e206</fpage>
            <page-range>e206-e217</page-range>
            <pub-id pub-id-type="pmid">28368259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsang</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Goda</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Kirova</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Parikh</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ricardi</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Mauch</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Specht</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yahalom</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2018</year>
            <month>Jul</month>
            <day>15</day>
            <volume>101</volume>
            <issue>4</issue>
            <fpage>794</fpage>
            <page-range>794-808</page-range>
            <pub-id pub-id-type="pmid">29976492</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jantunen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Koivunen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Putkonen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Siitonen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Juvonen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nousiainen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Autologous stem cell transplantation in patients with high-risk plasmacytoma.</article-title>
            <source>Eur J Haematol</source>
            <year>2005</year>
            <month>May</month>
            <volume>74</volume>
            <issue>5</issue>
            <fpage>402</fpage>
            <page-range>402-6</page-range>
            <pub-id pub-id-type="pmid">15813914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Papadimitriou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Anagnostopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitsibounas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fermand</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2003</year>
            <month>Jan</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>153</fpage>
            <page-range>153-5</page-range>
            <pub-id pub-id-type="pmid">12691157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Micco</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Di Micco</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Up-date on solitary plasmacytoma and its main differences with multiple myeloma.</article-title>
            <source>Exp Oncol</source>
            <year>2005</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-12</page-range>
            <pub-id pub-id-type="pmid">15812350</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seegmiller</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>McKenna</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Karandikar</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.</article-title>
            <source>Am J Clin Pathol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>176</fpage>
            <page-range>176-81</page-range>
            <pub-id pub-id-type="pmid">17210522</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nair</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Faizuddin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Malleshi</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Extramedullary plasmacytoma of gingiva and soft tissue in neck.</article-title>
            <source>J Clin Diagn Res</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>8</volume>
            <issue>11</issue>
            <fpage>ZD16</fpage>
            <page-range>ZD16-8</page-range>
            <pub-id pub-id-type="pmid">25584334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>You</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Qian</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>HQ</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>MY</given-names>
              </name>
            </person-group>
            <article-title>Establishment of an innovative staging system for extramedullary plasmacytoma.</article-title>
            <source>BMC Cancer</source>
            <year>2016</year>
            <month>Oct</month>
            <day>08</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>777</fpage>
            <pub-id pub-id-type="pmid">27717354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dimopoulos</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Hamilos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Solitary bone plasmacytoma and extramedullary plasmacytoma.</article-title>
            <source>Curr Treat Options Oncol</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>255</fpage>
            <page-range>255-9</page-range>
            <pub-id pub-id-type="pmid">12057071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weber</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Solitary bone and extramedullary plasmacytoma.</article-title>
            <source>Hematology Am Soc Hematol Educ Program</source>
            <year>2005</year>
            <fpage>373</fpage>
            <page-range>373-6</page-range>
            <pub-id pub-id-type="pmid">16304406</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>XM</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>ZJ</given-names>
              </name>
            </person-group>
            <article-title>Prognosis and expression of lambda light chains in solitary extramedullary plasmacytoma of the head and neck: two case reports and a literature review.</article-title>
            <source>J Int Med Res</source>
            <year>2010</year>
            <season>Jan-Feb</season>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>282</fpage>
            <page-range>282-8</page-range>
            <pub-id pub-id-type="pmid">20233540</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Diao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Extramedullary Plasmacytoma: Long-Term Clinical Outcomes in a Single-Center in China and Literature Review.</article-title>
            <source>Ear Nose Throat J</source>
            <year>2021</year>
            <month>May</month>
            <volume>100</volume>
            <issue>4</issue>
            <fpage>227</fpage>
            <page-range>227-232</page-range>
            <pub-id pub-id-type="pmid">32941076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marotta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Di Micco</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Solitary plasmacytoma of the jaw.</article-title>
            <source>J Blood Med</source>
            <year>2010</year>
            <volume>1</volume>
            <fpage>33</fpage>
            <page-range>33-6</page-range>
            <pub-id pub-id-type="pmid">22282681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wadhwa</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Raina</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kochupillai</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>POEMS syndrome: experience with fourteen cases.</article-title>
            <source>Leuk Lymphoma</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>44</volume>
            <issue>10</issue>
            <fpage>1749</fpage>
            <page-range>1749-52</page-range>
            <pub-id pub-id-type="pmid">14692529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadokura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tanio</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nonaka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kataoka</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kushima</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kimura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakamaki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Takaba</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>A surgical case of solitary plasmacytoma of rib origin with biclonal gammopathy.</article-title>
            <source>Jpn J Clin Oncol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>191</fpage>
            <page-range>191-5</page-range>
            <pub-id pub-id-type="pmid">10830989</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Auge</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yguel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Frotscher</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Busby-Venner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Morizot</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Moulin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Feugier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Perrot</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Filliatre-Clement</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Two Rare Complications in One Patient: Acquired von Willebrand Syndrome Associated with Intracranial Plasmacytoma.</article-title>
            <source>Case Rep Hematol</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>7609308</fpage>
            <pub-id pub-id-type="pmid">31534805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suvannasankha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abonour</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Liangpunsakul</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Gastrointestinal plasmacytoma presenting as gastrointestinal bleeding.</article-title>
            <source>Clin Lymphoma Myeloma</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>309</fpage>
            <page-range>309-11</page-range>
            <pub-id pub-id-type="pmid">18854287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comba</surname>
                <given-names>IY</given-names>
              </name>
              <name>
                <surname>Torres Luna</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>W Crespo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carilli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A Rare Case of Extramedullary Plasmacytoma Presenting as Massive Upper Gastrointestinal Bleeding.</article-title>
            <source>Cureus</source>
            <year>2019</year>
            <month>Jan</month>
            <day>31</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>e3993</fpage>
            <pub-id pub-id-type="pmid">30972272</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piccinini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Artusi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bonacorsi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Arigliano</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.</article-title>
            <source>Haematologica</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>2</issue>
            <fpage>EIM04</fpage>
            <pub-id pub-id-type="pmid">11836178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-135195.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodeghiero</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Elice</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Thalidomide and thrombosis.</article-title>
            <source>Pathophysiol Haemost Thromb</source>
            <year>2003</year>
            <volume>33 Suppl 1</volume>
            <fpage>15</fpage>
            <page-range>15-8</page-range>
            <pub-id pub-id-type="pmid">12954993</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
